關鍵數據
31.590今開
31.590最高
1.84M成交量
28.08本益比TTM
12.92本益比動
0.752股利TTM
0.43%換手率
32.330昨收
31.200最低
34.15M成交額
32.55本益比靜
2.54市淨率
2.38%股息率 TTM
4.62%ROA
38.79052週最高
0.83量比
412.00M淨利潤
424.86M總股本
1.1239每股盈餘TTM
0.59Beta
9.14%ROE
28.40052週最低
1.21%振幅
70.62%毛利率
13.41B總市值
6.52回報/風險
1.06%風險率
操作建議
Smith & Nephew PLC當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名92/199位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為32.94。中期看,股價處於平穩狀態。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
Smith & Nephew PLC新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Zimmer Biomet Holdings Inc
ZBH
31
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Smith & Nephew PLC簡介
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
公司代碼SNN
公司Smith & Nephew PLC
CEONath (Deepak S)
網址https://www.smith-nephew.com/
公司股東
常見問題
Smith & Nephew PLC(SNN)的當前股價是多少?
Smith & Nephew PLC(SNN)的當前股價是 31.53。
Smith & Nephew PLC 的股票代碼是什麼?
Smith & Nephew PLC的股票代碼是SNN。
Smith & Nephew PLC股票的52週最高點是多少?
Smith & Nephew PLC股票的52週最高點是38.79。
Smith & Nephew PLC股票的52週最低點是多少?
Smith & Nephew PLC股票的52週最低點是28.40。
Smith & Nephew PLC的市值是多少?
Smith & Nephew PLC的市值是13.40B。
現在Smith & Nephew PLC(SNN)的股票是買入、持有還是賣出?
根據分析師評級,Smith & Nephew PLC(SNN)的總體評級為signal_hold,目標價格為32.94。
Smith & Nephew PLC(SNN)股票的每股收益(EPS TTM)是多少
Smith & Nephew PLC(SNN)股票的每股收益(EPS TTM)是1.44。